Patient Monitoring
Prioritize low-noise analog paths, approved critical components, alarm test steps, connectivity and long-term revision control.

Medical PCB & PCBA
Medical PCB manufacturing turns a device's electrical, mechanical, cleanliness and traceability requirements into controlled bare-board and assembly outputs. APTPCB supports monitoring, imaging, IVD, therapeutic and wearable programs with HDI and rigid-flex options, inspection, and project-defined release evidence from prototype through production.
Use this matrix to convert device-level concerns into supplier controls, objective evidence and complete RFQ inputs.
| Buyer risk | PCB / PCBA control | Release evidence | RFQ input |
|---|---|---|---|
| Low-level signal integrity | Approved stackup, copper geometry and controlled-impedance process | Electrical test plus TDR or coupon data when specified | Impedance nets, target/tolerance, stackup and coupon requirement |
| Hidden solder-joint defects | Paste-process control, SPI/AOI and X-ray where package geometry requires it | Inspection result or report at the agreed coverage | Package list, acceptance criteria, coverage and report format |
| Residue or leakage paths | Defined cleaning process, handling controls and optional ionic cleanliness test | Cleanliness result when contracted | Flux/cleaning restrictions, limit, method, coating and keep-out areas |
| Isolation geometry | DFM review and manufacture of released creepage, clearance, slots and material | Dimensional and electrical inspection to drawing | Working voltage, insulation requirement, dimensions and acceptance limits |
| Revision or component drift | Released files, BOM/AVL control and agreed substitution/change process | Build revision, lot/serial traceability and approved deviation record | AVL, alternates, change-notification rule, labels and serialization |
| Environmental or lifetime failure | Build to the customer's qualification specimen and test specification | External or supplier test report only when included in scope | Profile, cycles, sample size, fixtures, limits and failure disposition |
Final device safety, clinical performance and regulatory conformity remain the responsibility of the legal manufacturer.
Representative capabilities used for initial sourcing. Exact feasibility, tolerances and evidence are confirmed against the released data during DFM and quotation.
| Parameter | Representative capability | RFQ note |
|---|---|---|
| Board formats | Rigid, flex, rigid-flex and HDI | Provide stackup, flex zones, stiffeners and bend requirements |
| Layer count | Up to 32 layers standard; advanced builds up to 64 after review | Sequential lamination and material availability affect feasibility |
| Fine lines | 3/3 mil (0.076 mm); 2/2 mil subject to DFM | Copper weight, finished geometry and yield assumptions apply |
| Laser microvias | 0.075–0.10 mm; blind, buried, stacked and via-in-pad options | Confirm aspect ratio, fill, stack and reliability requirements |
| Controlled impedance | ±5% when specified and feasible | Provide target, tolerance, stackup, material and coupon requirement |
| Materials | FR-4, high-Tg and halogen-free FR-4, polyimide, Rogers/PTFE and ceramic | Material selection and biocompatibility remain device-level decisions |
| Surface finishes | ENIG, immersion silver/tin, OSP, electrolytic gold and lead-free HASL | Select by assembly, contact, shelf-life and reliability requirements |
| Assembly | SMT to 01005, BGA/CSP pitch to 0.3 mm, mixed SMT/THT | Confirm package list, placement tolerances and X-ray coverage |
| Inspection and test | SPI, AOI, X-ray, electrical test, flying probe/ICT and customer-defined FCT | Method, coverage, limits and records are project-defined |
| Acceptance criteria | IPC Class 2 or Class 3 when specified | Identify applicable fabrication and assembly documents in the RFQ |
| Quality and compliance | ISO 9001:2015, UL; RoHS and REACH support | Request current certificates and confirm scope during qualification |
| Traceability | Lot-level and board-level options | Define serialization, record retention, labels and shipment dossier |
This is not a blanket approval for a medical device. The quotation and approved manufacturing data define the actual scope.
Prioritize low-noise analog paths, approved critical components, alarm test steps, connectivity and long-term revision control.
Prioritize HDI feasibility, controlled impedance, BGA inspection, high-layer registration, thermal interfaces and coupon evidence.
Prioritize contamination controls, cleaning limits, motor and heater loads, sensor interfaces and calibration or functional-test access.
Prioritize safety-critical AVL control, isolation geometry, power-stage inspection, interlocks and customer-defined functional limits.
Prioritize flex construction, bend zones, battery interfaces, miniaturization, coating zones and enclosure-level environmental validation.
Prioritize working-voltage inputs, creepage and clearance, slots, material control, thermal rise and system-level safety testing.
Share your fabrication data, BOM, assembly drawings, test scope and documentation requirements. We will confirm feasibility, quote assumptions and the proposed release evidence before build.
Do not assume ISO 13485 coverage from this page. APTPCB publishes ISO 9001:2015 and UL quality credentials; request the current certificates and scope during supplier qualification. If your program requires an ISO 13485-approved supplier, state that requirement in the RFQ and complete approval before nomination.
Provide fabrication data, stackup and impedance requirements, BOM and approved alternates, assembly drawings, annual and build quantities, acceptance class, inspection and test specifications, cleanliness or coating requirements, traceability level, labeling and the release documents you expect.
Yes, when IPC Class 3 is specified and the design, materials, process and inspection plan support it. State the applicable IPC fabrication and assembly criteria in the RFQ; APTPCB confirms feasibility and the required evidence during DFM and quotation.
Available controls can include SPI, AOI, X-ray for hidden joints, electrical test, flying probe or ICT, and customer-defined functional test. The exact test method, sampling or coverage, acceptance limits and report format must be agreed before the build.
No. PCB and PCBA manufacturing can implement agreed drawings, materials, acceptance criteria, traceability and release evidence. Final IEC 60601 performance, risk management, biocompatibility, clinical safety and regulatory approval remain device- and system-level responsibilities of the legal manufacturer.